The FDA approved the first blood-based colorectal cancer test, Epi proColon, earlier this year. However, gastroenterologists are unsure if the benefits outweigh the costs for this new screening method, according to Medscape.
GI & Endoscopy
The Palo Alto, Calif.-based biopharmaceutical company twoXAR and Stanford University School of Medicine's Asian Liver Center will collaborate to identify liver cancer treatments.
Here are four gastroenterologists in the news this past week.
The FDA recently issued a recommendation to healthcare facilities to stop using Custom Ultrasonics' System 83 plus for cleaning duodenoscopes, LawyersandSettlements.com reports.
The American Gastroenterological Association's government affairs committee is encouraging gastroenterologists to contact their Congressional representatives about increasing MACRA oversight.
Milena Bogunovic, MD, PhD, has received the $100,000 Kenneth Rainin Foundation Innovator Award.
Liat Hayardeny, PhD, MBA, has been named chief scientific officer of the Tel Aviv, Israel-based biopharmaceutical company Galmed Pharmaceuticals.
Takeda along with Texas Digestive Disease Consultants and the Vanderbilt University Medical Center are partnering to pilot a digital technology program to help manage inflammatory bowel disease for patients and providers.
The American Society for Gastrointestinal Endoscopy named Ed Dellert chief learning officer in June 2016.
Nutrition is an under-discussed element of inflammatory bowel disease care, according to a study out of Crohn's & Colitis Foundation of America.
